Skip to main content
OpenTrials

Clinical trial condition

Recurrent Ovarian Carcinoma

Explore clinical trials studying Recurrent Ovarian Carcinoma. Study availability and eligibility vary by location and protocol.

111 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Ovarian Carcinoma trial results

Active, Not Recruiting

Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer

NCT01012817

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT02101775

Conditions
Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +33 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

NCT01970722

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +43 more
Locations
  • City of Hope Corona Corona, California, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Upland Upland, California, United States
  • Parkview Hospital Randallia Fort Wayne, Indiana, United States
View Trial Details
Active, Not Recruiting

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00565851

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, +51 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 709 locations
View Trial Details
Active, Not Recruiting

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

NCT03949283

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Kaiser Permanente Los Angeles, California, United States
  • Miami Cancer Institute/Baptist Health South Florida Miami, Florida, United States
  • LSU Health Sciences Center New Orleans, Louisiana, United States
  • University of Cincinnati Cancer Institute Cincinnati, Ohio, United States
View Trial Details

Related conditions